• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体-丝裂原活化蛋白激酶信号通路对三阴性乳腺癌低密度脂蛋白受体表达的调控。

Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling.

机构信息

Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1055, New York, NY, 10029, USA.

Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.

出版信息

Sci Rep. 2021 Sep 9;11(1):17927. doi: 10.1038/s41598-021-97327-y.

DOI:10.1038/s41598-021-97327-y
PMID:34504181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8429745/
Abstract

Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL cholesterol and tumor LDLR might accelerate oncogenic processes by determining whether increased LDLR expression and cholesterol uptake are associated with the activation of the epidermal growth factor receptor (EGFR) signaling pathway in triple negative breast cancer (TNBC) cell lines. EGF stimulation of MDA-MB-468 (MDA468) cells activated p44/42MAPK (MAPK), increased expression of LDLR, and fluorescent LDL cholesterol uptake. However, stimulation of MDA-MB-231 (MDA231) cells with EGF did not lead to increased expression of LDLR despite inducing phosphorylation of EGFR. Inhibition of MAPK using UO126 in MDA231 cells reduced LDLR expression, and in MDA468 cells, UO126 impaired the LDLR increase in response to EGF. MDA468 cells exposed to the transcription inhibitor, Actinomycin, prior to treatment with EGF showed reduced degradation of LDLR mRNA compared to vehicle-treated cells. Our results suggest that the EGF-associated increase in LDLR protein expression is cell line-specific. The common pathway regulating LDLR expression was MAPK in both TNBC cell lines.

摘要

低密度脂蛋白受体(LDLR)的表达已被证明在高胆固醇血症相关的乳腺癌生长中发挥关键作用,并且与人类乳腺癌研究中无复发生存时间较短相关。我们试图通过确定循环 LDL 胆固醇和肿瘤 LDLR 是否通过增加 LDLR 表达和胆固醇摄取与三阴性乳腺癌(TNBC)细胞系中表皮生长因子受体(EGFR)信号通路的激活有关,来确定它们如何加速致癌过程。EGF 刺激 MDA-MB-468(MDA468)细胞激活 p44/42MAPK(MAPK),增加 LDLR 的表达,并摄取荧光 LDL 胆固醇。然而,EGF 刺激 MDA-MB-231(MDA231)细胞不会导致 LDLR 表达增加,尽管它诱导 EGFR 的磷酸化。在 MDA231 细胞中使用 UO126 抑制 MAPK 会降低 LDLR 的表达,而在 MDA468 细胞中,UO126 会损害 EGF 对 LDLR 增加的作用。与用载体处理的细胞相比,在用 EGF 处理之前用转录抑制剂放线菌素 D 处理的 MDA468 细胞中 LDLR mRNA 的降解减少。我们的结果表明,EGF 相关的 LDLR 蛋白表达增加是细胞系特异性的。两种 TNBC 细胞系中调节 LDLR 表达的共同途径是 MAPK。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/399c1d42f9c6/41598_2021_97327_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/dea4d49fdbc8/41598_2021_97327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/9c29aebe05e8/41598_2021_97327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/e6cdccaa3c77/41598_2021_97327_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/7f301a2d8348/41598_2021_97327_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/a4f89f347821/41598_2021_97327_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/c8c94fc6485c/41598_2021_97327_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/b6815213a86f/41598_2021_97327_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/399c1d42f9c6/41598_2021_97327_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/dea4d49fdbc8/41598_2021_97327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/9c29aebe05e8/41598_2021_97327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/e6cdccaa3c77/41598_2021_97327_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/7f301a2d8348/41598_2021_97327_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/a4f89f347821/41598_2021_97327_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/c8c94fc6485c/41598_2021_97327_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/b6815213a86f/41598_2021_97327_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af2a/8429745/399c1d42f9c6/41598_2021_97327_Fig8_HTML.jpg

相似文献

1
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling.表皮生长因子受体-丝裂原活化蛋白激酶信号通路对三阴性乳腺癌低密度脂蛋白受体表达的调控。
Sci Rep. 2021 Sep 9;11(1):17927. doi: 10.1038/s41598-021-97327-y.
2
Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.在高脂血症小鼠模型中,肿瘤低密度脂蛋白受体(LDLR)表达升高会加速低密度脂蛋白胆固醇介导的乳腺癌生长。
Oncogene. 2017 Nov 16;36(46):6462-6471. doi: 10.1038/onc.2017.247. Epub 2017 Jul 31.
3
PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.蛋白激酶Cθ(PRKCQ)促进一部分三阴性乳腺癌细胞的致癌生长和失巢凋亡抗性。
Breast Cancer Res. 2016 Sep 23;18(1):95. doi: 10.1186/s13058-016-0749-6.
4
Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.人参皂苷 20(S)-原人参二醇通过靶向 EGFR 介导的 MAPK 通路抑制三阴性乳腺癌的转移。
Pharmacol Res. 2019 Apr;142:1-13. doi: 10.1016/j.phrs.2019.02.003. Epub 2019 Feb 5.
5
Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.持续的丝裂原活化蛋白激酶激活是由转化型erbB受体复合物诱导的。
DNA Cell Biol. 1999 Oct;18(10):731-41. doi: 10.1089/104454999314872.
6
Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.在成纤维细胞生长因子1或神经调节蛋白β1诱导的乳腺癌细胞抗雌激素耐药性生长过程中,细胞外信号调节激酶1/2的持续激活对丝裂原活化蛋白/细胞外调节激酶激酶抑制剂具有抗性。
Cancer Res. 2004 Jul 1;64(13):4637-47. doi: 10.1158/0008-5472.CAN-03-2645.
7
Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.表皮生长因子通过多种分子相互作用在雌激素受体α阳性乳腺肿瘤细胞中诱导WISP-2/CCN5表达。
Mol Cancer Res. 2005 Mar;3(3):151-62. doi: 10.1158/1541-7786.MCR-04-0130.
8
Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.葡萄籽提取物抑制表皮生长因子(EGF)诱导的和组成型激活的促有丝分裂信号传导,但激活人前列腺癌DU145细胞中的JNK:在抗增殖和凋亡中的可能作用。
Oncogene. 2003 Mar 6;22(9):1302-16. doi: 10.1038/sj.onc.1206265.
9
Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.丝裂原活化蛋白激酶(MAPK)和磷脂酰肌醇-3-激酶/蛋白激酶B(PI3K/PKB)信号通路与姜黄素诱导乳腺细胞凋亡的相关性。
Biochem Pharmacol. 2003 Feb 1;65(3):361-76. doi: 10.1016/s0006-2952(02)01517-4.
10
EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.EBP50 通过阻断 EGFR 磷酸化抑制 EGF 诱导的乳腺癌细胞增殖。
Amino Acids. 2012 Nov;43(5):2027-35. doi: 10.1007/s00726-012-1277-z. Epub 2012 Apr 4.

引用本文的文献

1
Low-density lipoprotein receptor-targeting chimeras for membrane protein degradation and enhanced drug delivery.用于膜蛋白降解和增强药物递送的低密度脂蛋白受体靶向嵌合体
bioRxiv. 2025 Jun 9:2025.06.06.658366. doi: 10.1101/2025.06.06.658366.
2
Engineering Fusion Proteins for Nanomedicine-Based Cytokine Therapy.用于基于纳米医学的细胞因子治疗的工程融合蛋白
Bioconjug Chem. 2025 Aug 20;36(8):1698-1708. doi: 10.1021/acs.bioconjchem.5c00182. Epub 2025 Jul 11.
3
Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach.

本文引用的文献

1
Observing the nonvectorial yet cotranslational folding of a multidomain protein, LDL receptor, in the ER of mammalian cells.在哺乳细胞的内质网中观察到多结构域蛋白 LDL 受体的非向量性共翻译折叠。
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16401-16408. doi: 10.1073/pnas.2004606117. Epub 2020 Jun 29.
2
27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.27-羟基胆固醇损害质膜脂筏信号传导,前列腺癌细胞中IL6-JAK-STAT3信号传导的抑制证明了这一点。
Mol Cancer Res. 2020 May;18(5):671-684. doi: 10.1158/1541-7786.MCR-19-0974. Epub 2020 Feb 4.
3
膀胱癌免疫治疗中靶向代谢重编程:一种精准医学方法。
Biomedicines. 2025 May 9;13(5):1145. doi: 10.3390/biomedicines13051145.
4
A highly resolved integrated transcriptomic atlas of human breast cancers.一份高分辨率的人类乳腺癌综合转录组图谱。
bioRxiv. 2025 May 3:2025.03.13.643025. doi: 10.1101/2025.03.13.643025.
5
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.脂质代谢重编程:乳腺癌进展和肿瘤微环境中被忽视的英雄。
Mol Cancer. 2025 Mar 3;24(1):61. doi: 10.1186/s12943-025-02258-1.
6
Spatial and signaling overlap of growth factor receptor systems at clathrin-coated sites.网格蛋白包被位点上生长因子受体系统的空间和信号重叠。
Mol Biol Cell. 2024 Nov 1;35(11):ar138. doi: 10.1091/mbc.E24-05-0226. Epub 2024 Sep 18.
7
Crosstalk of growth factor receptors at plasma membrane clathrin-coated sites.生长因子受体在质膜网格蛋白包被位点处的相互作用。
bioRxiv. 2024 May 18:2024.05.16.594559. doi: 10.1101/2024.05.16.594559.
8
Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol.胆固醇通过其代谢产物 27-羟胆固醇中和维莫非尼治疗,促进黑色素瘤干细胞样细胞。
Cell Mol Life Sci. 2024 May 22;81(1):226. doi: 10.1007/s00018-024-05267-3.
9
Effect of H-NMR serum lipoproteins on immunotherapy response in advanced triple-negative breast cancer patients.氢核磁共振血清脂蛋白对晚期三阴性乳腺癌患者免疫治疗反应的影响。
Cancer Sci. 2023 Oct;114(10):3924-3934. doi: 10.1111/cas.15937. Epub 2023 Aug 28.
10
Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells.低密度脂蛋白受体是甲状腺肿瘤细胞侵袭性的关键驱动因素。
Int J Mol Sci. 2023 Jul 6;24(13):11153. doi: 10.3390/ijms241311153.
Lipid Metabolism at the Nexus of Diet and Tumor Microenvironment.
饮食与肿瘤微环境交汇处的脂质代谢
Trends Cancer. 2019 Nov;5(11):693-703. doi: 10.1016/j.trecan.2019.09.007. Epub 2019 Oct 31.
4
RNA-Binding Protein Suppresses Hypoxia and Cell-Cycle Signaling.RNA 结合蛋白抑制缺氧和细胞周期信号。
Cancer Res. 2020 Jan 15;80(2):219-233. doi: 10.1158/0008-5472.CAN-18-2796. Epub 2019 Sep 24.
5
Next-generation characterization of the Cancer Cell Line Encyclopedia.下一代癌症细胞系百科全书的特征描述。
Nature. 2019 May;569(7757):503-508. doi: 10.1038/s41586-019-1186-3. Epub 2019 May 8.
6
Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis.用截短的锌指蛋白 TIS11b/BRF1 的活性形式靶向 AU 富含元件介导的 mRNA 衰变可损害乳腺肿瘤发生的主要特征。
Oncogene. 2019 Jun;38(26):5174-5190. doi: 10.1038/s41388-019-0784-8. Epub 2019 Mar 26.
7
Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA.曲昔派特通过稳定 LDLR mRNA 增加 LDLR 表达和 LDL 摄取。
Sci Rep. 2018 Nov 1;8(1):16174. doi: 10.1038/s41598-018-34237-6.
8
PCSK9: From Basic Science Discoveries to Clinical Trials.PCSK9:从基础科学发现到临床试验。
Circ Res. 2018 May 11;122(10):1420-1438. doi: 10.1161/CIRCRESAHA.118.311227.
9
5-Azacytidine engages an IRE1α-EGFR-ERK1/2 signaling pathway that stabilizes the LDL receptor mRNA.5-氮杂胞苷通过一个 IRE1α-EGFR-ERK1/2 信号通路稳定 LDL 受体 mRNA。
Biochim Biophys Acta Gene Regul Mech. 2018 Jan;1861(1):29-40. doi: 10.1016/j.bbagrm.2017.11.010. Epub 2017 Dec 5.
10
Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.在高脂血症小鼠模型中,肿瘤低密度脂蛋白受体(LDLR)表达升高会加速低密度脂蛋白胆固醇介导的乳腺癌生长。
Oncogene. 2017 Nov 16;36(46):6462-6471. doi: 10.1038/onc.2017.247. Epub 2017 Jul 31.